Identification of host cell surface proteins inhibiting furin dependent proteolytic processing of viral glycoproteins.

Publication date: Jul 15, 2025

Proteolytic cleavage by furin-like proteases is a crucial first step in the posttranslational modification of various glycoproteins found in enveloped emerging viruses, such as SARS-CoV-2 and highly pathogenic avian influenza A viruses (IAV). Here, we explored the capacity of host cell proteins identified by cell surface proximity ligation to limit the proteolytic cleavage of the SARS-CoV-2 spike and the IAV H5N1 hemagglutinin (HA). When co-expressed with recombinant SARS-CoV-2 spike protein, Prom1, Axl, and Ly75 suppress its proteolytic cleavage, whereas cleavage of HA was only reduced by Prom1. Co-immunoprecipitation assays suggest that Axl and Prom1 may form a complex with furin. Alteration of Prom1, Axl and Ly75 expression levels in Calu3 cells affected entry of SARS-CoV-2 S pseudotyped VLP and to a lesser extent, SARS-CoV-2 virions. In contrast, Prom1 levels did not affect entry of H5N1 VLPs or H5N1 virions. Our data highlight the differential capacity of SARS-CoV-2 and IAV H5N1 to cope with newly identified host restriction factors of furin activity.

Open Access PDF

Concepts Keywords
Avian Animals
Glycoproteins Cell Line
Host COVID-19
Posttranslational Furin
Viruses Furin
FURIN protein, human
HEK293 Cells
Humans
Membrane Proteins
Membrane Proteins
Proteolysis
Proto-Oncogene Proteins
Proto-Oncogene Proteins
Receptor Protein-Tyrosine Kinases
Receptor Protein-Tyrosine Kinases
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
Virus Internalization

Semantics

Type Source Name
disease IDO host
disease MESH avian influenza
disease IDO protein
disease MESH infections
disease IDO process
pathway KEGG Virion
drug DRUGBANK Calcium
drug DRUGBANK Serine
disease MESH death
disease MESH Inflammation
drug DRUGBANK Coenzyme M
disease IDO assay
drug DRUGBANK Trypsin
disease IDO biological process
drug DRUGBANK Albendazole
disease IDO cell
drug DRUGBANK Aspartame
disease IDO site
disease IDO infection
disease MESH SARS CoV 2 infection
drug DRUGBANK Gonadorelin
drug DRUGBANK Influenza A virus

Original Article

(Visited 1 times, 1 visits today)